MTOR and cancer: It is already known that activation of these signals is a contributing factor to decreased radiation sensitivity [43], indicating target of mTOR, a downstream kinase of the phosphatidylinositol 3-kinase (PI3K)/AKT survival pathway, may be a target for radiation sensitizing several human cancer cell lines.